Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk
Commack, New York, United States
- Memorial Sloan Kettering West Harrison
Harrison, New York, United States
- North Shore Lij
New Hyde Park, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Memorial Sloan Kettering Cancer Center at Mercy Medical Center
Rockville Centre, New York, United States
- Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center
Sleepy Hollow, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2012
- Primary completion
- 3 Sept 2025
- Completion
- 3 Sept 2025
- Last update posted
- 11 Sept 2025
- Registered enrollment
- 23
- Registry id
- NCT01745588
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.